IF
IRWD icon

Ironwood Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ironwood Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,194
Closed -$16K – 332
2015
Q1 		$16K Hold
1,194
– – 0.01% 175
2014
Q4 		$15K Buy
+1,194
New +$13.7K 0.01% 155

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Ironwood Financial's IRWD Position: Q2 2015 in Review

Ironwood Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2015, closing a stake of 1,194 shares — an estimated $16K sold.

Ironwood Financial first reported a position in IRWD in Q4 2014 and held it in 2 quarters. The position peaked at $16K in Q1 2015. 137 funds tracked by Wall St. Rank hold IRWD as of Q2 2015.

  • Ironwood Financial reported no remaining Ironwood Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Ironwood Financial sold 1,194 Ironwood Pharmaceuticals shares in Q2 2015, an estimated $16K.
  • Ironwood Financial first reported a position in Ironwood Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Ironwood Financial's Ironwood Pharmaceuticals position peaked at $16K in Q1 2015.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2015.

Based on Ironwood Financial's 13F filing for Q2 2015, filed 13 Aug 2015.